VRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Valeant Pharmaceuticals International Inc's quarterly accounts payable declined from Sep. 2014 ($2,317 Mil) to Dec. 2014 ($2,276 Mil) but then increased from Dec. 2014 ($2,276 Mil) to Mar. 2015 ($2,777 Mil).
Valeant Pharmaceuticals International Inc's annual accounts payable increased from Dec. 2012 ($1,236 Mil) to Dec. 2013 ($1,868 Mil) and increased from Dec. 2013 ($1,868 Mil) to Dec. 2014 ($2,276 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Valeant Pharmaceuticals International Inc Annual Data
Valeant Pharmaceuticals International Inc Quarterly Data